Breaking News

Novartis AG (NOVNEE)

Symbol	Exchange	Currency
NOVNEE	Switzerland	CHF	Delayed
NOVN	Switzerland	CHF	Delayed
NOVNz	BATS Europe	CHF	Delayed
NVSEF	OTC Markets	USD	Delayed
NVS	NYSE	USD	Real-time
0QLR	London	CHF	Real-time
NVSN	Mexico	MXN	Delayed
NVSy	TradeGate	EUR	Delayed
NVSm	Buenos Aires	ARS	Delayed
N1VS34	B3	BRL	Delayed

Add to/Remove from a Portfolio Add to Watchlist

95.95 +0.23 +0.24%

00:32:46 - Delayed Data. Currency in CHF

Volume: 308,926
Bid/Ask: 95.95 / 96.02
Day's Range: 95.52 - 96.04

Type: Equity

Market: Switzerland

ISIN: CH0038459415

VALOR: 3845941

General
Chart
- Streaming Chart
- Interactive Chart
News & Analysis
- News
- Analysis & Opinion
Financials
Technical
Forum

Novartis AG Company Profile

Get an in-depth profile of Novartis AG, including a general overview of the company's business and key management, as well as employee data and location and contact information.

IndustryPharmaceuticals

SectorHealthcare

Employees

76057

Equity Type

ORD

Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor for the treatment of symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocytopenia (ITP), thrombocytopenia, and patients with severe aplastic anemia (SAA); Tafinlar+Mekinist, an oral combination therapy to treat patients with certain types of cancers; and Jakavi for the treatment of myelofibrosis, polycythemia vera, and acute or chronic graftversushost disease (GvHD). It also provides Tasigna to treat philadelphia chromosomepositive chronic myeloid leukemia in the chronic and/or accelerated phase; Xolair for the treatment of allergic asthma and nasal polyps or severe chronic rhinosi nusitis with nasal polyps; Ilaris to treat fever syndromes, Still’s disease, and acute gouty arthritis; Pluvicto to treat prostatespecific membrane anti genpositive metastatic castrationresistant prostate cancer; Sandostatin SC and Sandostatin LAR to treat acromegaly carcinoid tumors and other types of functional gastro intestinal and pancreatic neuroendocrine tumors; Zolgensma for the treatment of genetic root cause of spinal muscular atrophy; Lucentis; Leqvio to reduce LDL cholesterol; Lutathera; Scemblix; and Fabhalta. The company focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, oncology, and hematology. It has a license and collaboration agreement with Alnylam Pharmaceuticals, Inc. to develop, manufacture, and commercialize Leqvio (inclisiran), a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.

Contact Information

Address Lichtstrasse 35
Basel, 4056
Switzerland

Phone 41 61 324 11 11

Fax 41 61 324 80 01

Web www.novartis.com

Top Executives

Name	Age	Since	Title
Joerg Reinhardt	69	1999	Independent Non-Executive Chairman
Daniel Luzius Vasella	72	1996	Honorary Chairman
Simon E. Moroney	66	2020	Independent Vice Chairman of the Board
William Thomas Winters	64	2013	Independent Non-Executive Director
Charles L. Sawyers	66	2013	Independent Non-Executive Director
Elizabeth Doherty	68	2016	Independent Non-Executive Director
Nancy C. Andrews	67	2015	Independent Non-Executive Director
Ton Buechner	60	2016	Independent Non-Executive Director
Bridgette P. Heller	64	2020	Independent Non-Executive Director
François Adrianus van Houten	65	2017	Independent Non-Executive Director
Ana María de Pro Gonzalo	58	2022	Independent Non-Executive Director
Patrice Bula	69	2019	Lead Independent Director
John D. Young	61	2023	Non-Executive Independent Director
Daniel Hochstrasser	65	2022	Independent Director

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:

Enrich the conversation
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically.
Use standard writing style. Include punctuation and upper and lower cases.
NOTE: Spam and/or promotional messages and links within a comment will be removed
Avoid profanity, slander or personal attacks directed at an author or another user.
Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I have read and understood Investing.com Australia's comment guidelines and agree to the terms described.

I Agree

NOVNEE Comments

Write your thoughts about Novartis AG

Are you sure you want to delete this chart?

Delete Cancel

Post

Post also to:

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.

<div id="comment">
				<div class="comment js-comment" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
    <div class="mainComment js-content">
       <div class="commentInnerWrapper">
        <a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody">
                					<span class="commentUsername">
                    	<a href="{userLink}" class="js-user-link js-user-name">{username}</a>
					</span>
                                <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
                <div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

<div class="js-option addRow follow">
            <div class="js-follow-post-button" data-reg_ep="follow comment">
                <span class="alertfollowIcon middle"></span>Follow this post            </div>
            <div class="js-unfollow-post-button displayNoneImp">
                <span class="alertUnfollowIcon middle"></span>Unfollow this post            </div>
        </div>

<div class="addRow js-option save"  data-reg_ep="save comment">
		<a href="javascript:void(0);" class="js-save-item-btn" data-item-type="comments" data-item-id="{commentID}">
			<i class="saveItemBigIcon middle"></i>
			Save		</a>
	</div>
	<div class="addRow saveItemsConfirmation noHover displayNone js-saveItemResult">
		
<div class="content js-saveItemSuccess displayNone">
	<span class="mediumGreenSuccessIcon"></span><span>Saved. See <a href="/members-admin/saved-items" target="_blank">Saved Items</a>.</span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
<div class="content js-saveItemAlreadySaved saveItemAlreadySaved displayNoneImp">
	<span>This comment has already been saved in your <a href="/members-admin/saved-items" target="_blank">Saved Items</a></span>
	<a href="javascript:void(0);" class="bugCloseIcon js-close"></a>
</div>
	</div>

<div class="addRow shareButtons js-sharePopup displayNone">
			<div class="js-shareComment"><span class="js-shareCommentSpan"></span></div>
		</div>
	</div>
</div>
                 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div>             </div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="commentBigChart js-comment-chart" onclick="openViewChartPopup('{commentID}')">
					<img src="https://d70-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

<div class="reportComment js-flag float_lang_base_2">
                            <a href="javascript:void(0);" id="commentFlag_{commentID}">
                                <span class="reportCommentIcon middle"></span><span class="inlineblock middle">Report</span>
                            </a>
                        </div>
                    				</div>
					</div>
	   </div>
	</div>
	</div>			</div>
			<div id="reply">
				
    <div class="commentReply js-comment js-comment-reply" data-comment-id="{commentID}" id="comment-{commentID}" data-user-id="">
		<div class="commentInnerWrapper"><a href="{userLink}" class="js-user-link"><img src="{userImage}" width="33" height="33" alt="{usernameAlt}" class="img" onerror="this.src='https://i-invdn-com.investing.com/defaultUserMaleTmp.png';"></a><div class="commentBody js-content">
            				<span class="commentUsername">
					<a href="{userLink}" class="commentUsername js-user-link js-user-name" onMouseOver="">{username}</a>
				</span>
                        <span class="js-date" comment-date="{dateFormat}" comment-date-formatted="{dateFormatted}" title="{dateTitle}">Just Now</span>
			 <div class="commentAuthor js-comment-by-author"><span class="commentAuthorIcon"></span>Author's response</div> 			<div class="commentDropDown js-commentDropDownWrapper " data-user-id="" data-cid="{commentID}">
	<a href="javascript:void(0);" class="threeDotsIconSmall js-thinDropdownArrow"></a>
	<div class="tooltipPopup commentActionsPop noHeader js-commentDropDownOptions displayNone">
		<div class="addRow js-option share">
			<a href="javascript:void(0);" class="js-commentSharePopup" data-cid="{commentID}" data-curl="{commentLink}"><span class="smallShareIcon middle"></span>Share</a>
		</div>

</div>
		<div id="commentText-{commentID}" class="js-text-wrapper commentText withImage">
							<div id="commentBigChart{commentID}" class="replyBigChart displayNone js-comment-chart">
					<img src="https://d70-invdn-com.investing.com/comments_images/{commentImage}" alt="{commentAlt}">
					<i class="newMagnifyChartIcon"></i>
				</div>
				<span id="commentSmallChart{commentID}" class="commentSmallChart pointer js-comment-chart" onclick="openViewChartPopup('{commentID}')">
                    <img src="https://d70-invdn-com.investing.com/comments_images/{commentImageSmall}" width="116" height="52" alt="{commentAlt}">
                    <span class="chartMagnifyOverlay displayNone"></span>
                    <span class="searchGlassIcon chartMagnify displayNone"></span>
                </span>
						<span class="js-text">{commentContent}</span>
			<div class="clear"></div>
							<div class="commentButtons js-not-master-user">
					<a href="javascript:void(0)" class="reply js-reply-btn" data-real-parent-id="{commentID}" data-to-user-name="{username}" data-to-user-id="">Reply</a>
					<div class="inlineblock likeDislikeBox js-like-dislike-box" data-item-id="{commentID}">
	<input class="js-like-checkbox" type="checkbox" name="option" value="Yes" id="like_{commentID}">
	<label for="like_{commentID}" class="like" title="I agree"></label>
	<span class="numOfLikes js-like-count lighterGrayFont">0</span>
	<input class="js-dislike-checkbox" type="checkbox" name="option" value="No" id="dislike_{commentID}">
	<label for="dislike_{commentID}" class="dislike" title="I disagree"></label>
	<span class="numOfDislikes js-dislike-count lighterGrayFont">0</span>
</div>

Are you sure you want to delete this chart?

Delete Cancel

Post

Replace the attached chart with a new chart ?

Replace Cancel

1000

Comment Guidelines

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.

Please wait a minute before you try to comment again.

I feel that this comment is:

Spam

Offensive

Thank You!

Your report has been sent to our moderators for review

More Categories

1D1W1M6M1Y5YMax

S&P/ASX 200	8,481.00	-56.10	-0.66%
ASX 200 Futures	8,456.5	-57.5	-0.68%
ASX All Ordinaries	8,756.70	-55.20	-0.63%
US 500	6,137.4	+22.8	+0.37%
Dow Jones	44,546.08	-165.35	-0.37%
China A50 Futures	13,358.5	+20.5	+0.15%
Dollar Index	106.910	+0.335	+0.31%

Crude Oil WTI	71.16	+0.45	+0.64%
Natural Gas	3.685	-0.040	-1.07%
Gold	2,933.79	+33.09	+1.14%
Silver	33.053	+0.198	+0.60%
Copper	4.5685	-0.0960	-2.06%
US Sugar #11	20.67	+0.25	+1.22%
US Coffee C	406.68	-0.72	-0.18%

Australia 10Y	4.542	+0.059	+1.32%
Australia 5Y	4.066	+0.052	+1.30%
New Zealand 10Y	4.656	+0.023	+0.43%
U.S. 10Y	4.518	+0.042	+0.94%
Japan 10Y	1.418	-0.013	-0.91%
China 10Y	1.702	+0.022	+1.31%
Singapore 10Y	2.852	+0.026	+1.06%

CSL	263.82	+5.52	+2.14%
Woolworths	30.780	-0.100	-0.32%
ANZ Holdings	30.610	-0.550	-1.77%
Commonwealth Bank Australia	162.600	-2.370	-1.44%
Telstra Group	3.890	+0.010	+0.26%
National Australia Bank	39.510	-1.010	-2.49%
BHP Group Ltd	40.970	+0.170	+0.42%

Recent Quotes

	Name	Price	Chg.	Chg. %
	NOVNEE	95.95	+0.23	+0.24%

Market Movers

Name	Last	Chg. %	Vol.
Westpac Banking	32.310	-2.97%	8.01M
BHP Group Ltd	40.970	+0.42%	6.94M
Woodside Energy	23.490	-1.47%	6.88M
Goodman Group	35.980	+2.13%	5.18M
National Australia Bank	39.510	-2.49%	4.83M
Commonwealth Bank Australia	162.600	-1.44%	2.53M
CSL	263.82	+2.14%	1.39M

Name	Last	Chg. %	Vol.
Enlitic DRC	0.09	+51.72%	4.28M
Diablo Resources	0.03	+50.00%	36.13M
Burgundy Diamond Mines	0.065	+41.67%	6.56M
Mont Royal Resources	0.041	+31.25%	37.03K
Syntara	0.086	+28.17%	14.82M
Scalare Partners	0.195	+25.81%	10.00K
Magontec Ltd	0.255	+23.81%	2.50K

Name	Last	Chg. %	Vol.
BSA Ltd	0.160	-83.84%	26.10M
Propell Holdings	0.01	-52.63%	1.32M
Exinol Wellness	0.029	-27.78%	44.81K
Buxton Resources Ltd	0.032	-26.32%	579.43K
NAOS Small Cap	0.315	-26.19%	1.38M
Australian Rare Earths	0.08	-20.20%	483.61K
Killi Resources	0.05	-16.67%	273.95K